Skip to content

Comparison of two different types of fluids on blood clotting parameters in patients undergoing neurosurgical procedures

Comparison of crystalloids versus colloids on coagulation profile by Sonoclot in patients undergoing neurosurgical procedures.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040513
Enrollment
110
Registered
2022-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G978- Other intraoperative and postprocedural complications and disorders of nervous system

Interventions

Intervention1: collodis - hydroxyethyl starch is given to patients: Hydroxyethyl starch has been used as maintenance intravenous fluids along with crystalloid fluids Control Intervention1: coagulation

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patients undergoing Craniectomy for Brain pathologies • Age between 18 to 65 years • ASA I and II patients

Exclusion criteria

Exclusion criteria: 1. Patient refusal for consent 2. Extremes of age ( 65 years) 3. Pregnancy 4. Patients with known bleeding disorders/coagulopathy (Platelets 5. Patients on antiplatelets and anticoagulants 6. Patients with uncontrolled systemic disease (DM, HTN, CKD, Liver failure, CAD) 7. Chronic NSAIDS within recent 2 weeks prior to surgery 8. Chronic alcohol or drug abuse 9. Massive blood loss

Design outcomes

Primary

MeasureTime frame
Change in coagulation parameters from baseline and at the end of surgery using Sonoclot in both the groupsTimepoint: baseline to end of surgery

Secondary

MeasureTime frame
1. Hemodynamic stability intraoperatively 2. Brain relaxation score (BRS) at opening and the end of surgery 3. Total blood loss 4. Intraoperative total fluid volume, Blood and blood products 5. Serum lactate levels/ Serum electrolytes 6. Renal functions 24 hours and 48 hours after surgery (Serum Cystatin-C levels and AKIN criteria) 7. Outcome at discharge by Modified Rankin Scale (MRS) Timepoint: 1. Hemodynamic stability - Intraoperative period 2. Brain relaxation score - at the opening of dura and closure of the dura 3. total blood loss - intraoperative period 4. Intraoperative total fluid volume, Blood and blood products - intraoperative period 5. Serum lactate levels/ Serum electrolytes - baseline, at the start of blood loss, at maximum allowable blood loss and at the end of surgery 6. Renal functions at 24 hours and 48 hours after surgery 7. Outcome by MRS - at discharge

Countries

India

Contacts

Public ContactDr Kiran Jangra

PGIMER

drkiransharma0117@gmail.com9914844330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026